Through years of disruption and advancement, the retail industry has evolved tremendously to meet the increased demands of a broadening consumer base. However not every industry – and most notably healthcare — has progressed with the times and buyers’ needs.
The healthcare supply chain specifically must expand beyond its antiquated roots to better serve buyers. Just as in retail, where the U.S. has seen exponential growth over the last 20 years, according to the U.S. Census Bureau, the
Read More
Top Security Certifications Required for Data Protection
How secure is your data? If your organization does not have the right security certifications in place, it’s not a matter of if a data breach will occur – but when. A lack of regulatory compliance, network and technical vulnerabilities, unencrypted information, unsecured mobile devices, and weak credentials all play a part in putting a healthcare organization at risk for a data breach.
Today, the cost of a data breach comes with a hefty price tag – an average of $9.44 million in the
Read More
Why It’s Time for Intelligent Prior Authorization
The Centers for Medicare & Medicaid Services (CMS) recently proposed a new rule to advance interoperability and improve the prior authorization (PA) process for Medicare and Medicaid patients. Specifically, the rule stipulates that health plans adopt electronic prior authorization processes, adhere to shorter turnaround times, clearly communicate denial reasons, publish key metrics annually, and implement the Fast Healthcare Interoperability Resources (FHIR) Application Programming Interface
Read More
FHIR Adoption and Implementation Challenges
The Fast Healthcare Interoperability Resources (FHIR) standard was introduced by HL7 in 2014 as a significant replacement for the HL7 V2 and V3 standards. An open standard called FHIR, which was initially drafted in 2011 makes it easier than ever for legacy systems and new apps to exchange data. FHIR was created to not only increase communication efficiency and interoperability compared to earlier standards but also to facilitate implementation by giving clear specifications and allowing
Read More
Why Researchers Should Explore New Apps of Machine Learning
As the amount of real-world data (RWD) in the pharmaceutical industry continues to grow, so does the usage of machine learning (ML) to analyze that data and gain insights. In fact, in a recent survey, 95% of life sciences executives said they expect to utilize ML in the next few years to generate real-world evidence (RWE) from this data.
With such a large and growing volume of data available, researchers may be wondering how they can take advantage of all of it to enhance and expand the
Read More
5 Key Trends in Women’s Health Technology for 2023 to Watch
Women's healthcare faces an uphill battle after centuries of being ignored. Yet, ironically enough, women currently share half of the consumerism market, hold power over 80% of household financial decisions, and make 70% of healthcare-related choices in their families.
Despite this, their access to proper healthcare often comes up short.
But with the market for women's healthcare predicted to be worth over $47 billion, changes are starting to occur. And with the recent attacks and laws on
Read More
Electronic Transactions Can Benefit Partnership Among Physicians, Insurers and TPAs
The patient is at the center of the healthcare experience, and rightfully so. However, a strong case can be made to place the physician at the center. After all, it’s the physician who diagnoses and treats the patient.
Insurance companies and third-party administrators (TPAs) also have critical roles to play in the care experience, bringing together networks of physicians, specialists, surgery centers, hospitals, ambulatory care centers, and more to create a comprehensive care experience for
Read More
The New “Front Door” to Healthcare Can Only Open Fully with True Interoperability
Some people think of retail pharmacists as standing behind the counter bottling pills, answering insurance questions, or discussing side effects with a customer.
But the COVID pandemic fundamentally changed the role of the neighborhood pharmacist, from primarily dispensing medication to increasingly being the source of urgent and primary care for patients. With the successful administration of more than 300 million COVID vaccinations, an ongoing doctor shortage, and
Read More
Develop, Partner, Acquire or Avoid – Where’s Investment for Digital Pathology Headed in 2023?
News of Fujifilm’s recent acquisition of software provider Inspirata’s digital pathology assets was met with much interest last month, following on from robust industry debate at Global Engage’s Digital Pathology and AI Congress: Europe a few weeks prior. Their discussions centered around the progress of the market and its inevitable future developments.
Whilst our in-depth analysis of the implications of Fujifilm’s specific deal will be released soon as a part of our Premium Insights
Read More
2023’s Biggest Pharma Cybersecurity Threats to Watch
Due to the recent growth of the pharmaceutical industry, the value of highly-sensitive data stored in pharmaceutical systems and the degree of the potential damage that cyberattacks on the industry can cause, it is safe to say that pharma could be one of the most targeted industries by cybercriminals in 2023. Ransomware, phishing attacks, business applications and third-party vendors will be some of the biggest threats to this key vertical as we approach the new year.
RansomwareThe threat of
Read More
